Suggested Dosing
Dried leaves steeped in hot water 10 min
No typical dosing guidelines
Suggested Uses
Relieve mental and physical fatigue,diuretic, mood modifyer, analgesic, depression, weight loss
Efficacy
More studies are needed to determine effetiveness
Interactions
Interaction Checker
No Results

Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor

Contraindicated (0)
Serious - Use Alternative (0)
Monitor Closely (0)
Minor (12)
- armodafinil
yerba mate increases effects of armodafinil by pharmacodynamic synergism. Minor/Significance Unknown.
- caffeine
yerba mate increases effects of caffeine by pharmacodynamic synergism. Minor/Significance Unknown.
- dexmethylphenidate
yerba mate increases effects of dexmethylphenidate by pharmacodynamic synergism. Minor/Significance Unknown.
- dextroamphetamine
yerba mate increases effects of dextroamphetamine by pharmacodynamic synergism. Minor/Significance Unknown.
- lisdexamfetamine
yerba mate increases effects of lisdexamfetamine by pharmacodynamic synergism. Minor/Significance Unknown.
- methamphetamine
yerba mate increases effects of methamphetamine by pharmacodynamic synergism. Minor/Significance Unknown.
- methylenedioxymethamphetamine
yerba mate increases effects of methylenedioxymethamphetamine by pharmacodynamic synergism. Minor/Significance Unknown.
- methylphenidate
yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Minor/Significance Unknown.
- modafinil
yerba mate increases effects of modafinil by pharmacodynamic synergism. Minor/Significance Unknown.
- phentermine
yerba mate increases effects of phentermine by pharmacodynamic synergism. Minor/Significance Unknown.
- serdexmethylphenidate/dexmethylphenidate
yerba mate increases effects of serdexmethylphenidate/dexmethylphenidate by pharmacodynamic synergism. Minor/Significance Unknown.
- yohimbine
yerba mate increases effects of yohimbine by pharmacodynamic synergism. Minor/Significance Unknown.
Adverse Effects
Frequency Not Defined
Hypertension
Excess stimulation
Inhib. platelet aggregation
Increased risk of esophageal cancer (heavy use)
Warnings
Contraindications
Hypertension
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
2% caffeine content